Formulation and In Vitro Evaluation of Ashwagandha Extract-Loaded Ethosomal Gel for Diabetes Management

Objective: The aim of the present study to develop, optimize and characterize ethosomal gel formulation loaded with ashwagandha leaf extract for improved transdermal delivery of Withanolide A for enhanced antidiabetic activity Methods: Ethosomes loaded with Ashwagandha leaf extract were formulated by thin film hydration method and optimized by Box-Behnken design. Ethosomes were evaluated for vesicle size, PDI, Zeta potential and entrapment efficiency. Optimized ethosomes were incorporated into carbopol gel base of different concentration and evaluated for various properties such as appearance, homogeneity, pH, viscosity, and spreadability including Ex-vivo skin permeation study. The antidiabetic activity of optimized gel formulation was assessed in vitro using the α-amylase enzyme inhibition assay and compared with the gel formulation loaded with extract. Results: The optimized ethosomes had vesicle size of 59.338± 0.016 nm with polydispersiblity index of 0.412±0.002 and percentage entrapment efficiency of 92.355± 0.024. The ethosomal gel formulation (F3) containing carbopol of concentration 1.5% was chosen as optimized ethosomal gel formulation based on good appearance, required spreadability and viscosity. In addition, it also showed high permeation and sustained release of withanolide A with flux value of 248.5 (µg/cm²/hr) from ethosomal gel formulation in comparison to gel formulation loaded with ashwagandha leaf extract. Ethosomal gel formulation also showed higher percentage of alpha amylase inhibitory activity of 33.66% in comparison to extract loaded into gel base indicating improved antidiabetic activity in vitro. Conclusion: Incorporation ashwagandha leaf extract into ethosomal gel formulation showed enhancement in the solubility and bioavailability of withanolide A for antidiabetic activity and there by proving that ethosomes are potential as nanocarriers in delivering withanolides for the treatment of Diabetes

Authors

Institutions

Publication Details

Journal
International Journal of Applied Pharmaceutics
Published
2026-11-07
DOI
https://doi.org/10.22159/ijap.2026v18i6.60356
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Formulation and In Vitro Evaluation of Ashwagandha Extract-Loaded Ethosomal Gel for Diabetes Management

Divya Jyothi, SAMIKSHA, PRAPEKSHA
International Journal of Applied Pharmaceutics
Advancements in Transdermal Drug Delivery
article

Formulation and In Vitro Evaluation of Ashwagandha Extract-Loaded Ethosomal Gel for Diabetes Management

Divya Jyothi, SAMIKSHA, PRAPEKSHA
article en

Abstract

Objective: The aim of the present study to develop, optimize and characterize ethosomal gel formulation loaded with ashwagandha leaf extract for improved transdermal delivery of Withanolide A for enhanced antidiabetic activity Methods: Ethosomes loaded with Ashwagandha leaf extract were formulated by thin film hydration method and optimized by Box-Behnken design. Ethosomes were evaluated for vesicle size, PDI, Zeta potential and entrapment efficiency. Optimized ethosomes were incorporated into carbopol gel base of different concentration and evaluated for various properties such as appearance, homogeneity, pH, viscosity, and spreadability including Ex-vivo skin permeation study. The antidiabetic activity of optimized gel formulation was assessed in vitro using the α-amylase enzyme inhibition assay and compared with the gel formulation loaded with extract. Results: The optimized ethosomes had vesicle size of 59.338± 0.016 nm with polydispersiblity index of 0.412±0.002 and percentage entrapment efficiency of 92.355± 0.024. The ethosomal gel formulation (F3) containing carbopol of concentration 1.5% was chosen as optimized ethosomal gel formulation based on good appearance, required spreadability and viscosity. In addition, it also showed high permeation and sustained release of withanolide A with flux value of 248.5 (µg/cm²/hr) from ethosomal gel formulation in comparison to gel formulation loaded with ashwagandha leaf extract. Ethosomal gel formulation also showed higher percentage of alpha amylase inhibitory activity of 33.66% in comparison to extract loaded into gel base indicating improved antidiabetic activity in vitro. Conclusion: Incorporation ashwagandha leaf extract into ethosomal gel formulation showed enhancement in the solubility and bioavailability of withanolide A for antidiabetic activity and there by proving that ethosomes are potential as nanocarriers in delivering withanolides for the treatment of Diabetes

International Journal of Applied Pharmaceutics
Nitte University (IN)
Openalex Percentile: Top 17%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon